TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17237993

Group type: EXPERIMENTAL
Intervention: New health sector reform program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Other types of units
Number of subjects: 0
Study: 12556735

Group type: EXPERIMENTAL
Intervention: Fenoldopam (a selective dopamine-1 receptor agonist)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 10878675

Group type: EXPERIMENTAL
Intervention: Idazoxan (40 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 8932264

Group type: EXPERIMENTAL
Intervention: Tacrolimus-based immunosuppression (female donors)
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: Tacrolimus-based immunosuppression (pediatric en bloc kidneys)
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: Tacrolimus-based immunosuppression (donors over 60 years of age)
Number of subjects: 397
Study: 1546122

Group type: EXPERIMENTAL
Intervention: Moclobemide
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 3920390

Group type: EXPERIMENTAL
Intervention: Superstuff
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control
Number of subjects: 43
Study: 31904578

Group type: EXPERIMENTAL
Intervention: Standard-fully automated emails (S)
Number of subjects: 458

Group type: EXPERIMENTAL
Intervention: Standard plus personalized SMS (S+pSMS)
Number of subjects: 458

Group type: EXPERIMENTAL
Intervention: Standard plus weekly videoconferencing support (S+VCS)
Number of subjects: 458
Study: 30087557

Group type: EXPERIMENTAL
Intervention: Creative expression therapy (CrExp)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Standard cognitive training (Control)
Number of subjects: 93
Study: 27776442

Group type: EXPERIMENTAL
Intervention: 6-month aerobic exercise intervention
Number of subjects: 161

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 161
Study: 25012003

Group type: EXPERIMENTAL
Intervention: Perindopril 5mg daily for three months prior to surgery
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo treatment daily for three months prior to surgery
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Perindopril 5mg
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: ACE inhibitor treatment
Number of subjects: 47
Study: 22100423

Group type: EXPERIMENTAL
Intervention: V.A.C.™ system (group A)
Number of subjects: 42

Group type: COMPARATOR
Intervention: RENASYS GO™ - F/P (group B)
Number of subjects: 42
Study: 20309785

Group type: EXPERIMENTAL
Intervention: Stretching groups (6 groups with different techniques and durations)
Number of subjects: 173

Group type: COMPARATOR
Intervention: Control group (no stretching)
Number of subjects: 173
Study: 18778329

Group type: EXPERIMENTAL
Intervention: Community-based HIV prevention intervention
Number of subjects: 6791

Group type: COMPARATOR
Intervention: Deferred intervention implementation (Control)
Number of subjects: 6791
Study: 15917842

Group type: EXPERIMENTAL
Intervention: Low-dose ghrelin infusion (1 pmol/kg/min)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: High-dose ghrelin infusion (5 pmol/kg/min)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ghrelin infusion
Number of subjects: 24
Study: 12069875

Group type: EXPERIMENTAL
Intervention: Intermittent injections of a staphylococcus toxoid
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 10353862

Group type: EXPERIMENTAL
Intervention: Thalidomide 200 mg/day
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 8955542

Group type: EXPERIMENTAL
Intervention: NART-R
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: NART
Number of subjects: 47
Study: 1770183

Group type: EXPERIMENTAL
Intervention: methylphenidate (0.3 mg/kg)
Number of subjects: 21

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 21
Study: 7048770

Group type: EXPERIMENTAL
Intervention: combined diet training programme
Number of subjects: 23

Group type: COMPARATOR
Intervention: unique dietary treatment
Number of subjects: 23
Study: 31574151

Group type: COMPARATOR
Intervention: No intervention (untreated)
Number of subjects: 43
Study: 28952824

Group type: EXPERIMENTAL
Intervention: Simvastatin/beta-TCP combination
Number of subjects: 6

Group type: COMPARATOR
Intervention: beta-TCP
Number of subjects: 6
Study: 26787567

Group type: EXPERIMENTAL
Intervention: NAC 1200 mg orally before angiography and 1200 mg orally twice daily for three doses along with good hydration
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: NAC 600 mg before angiography and 600 mg orally twice daily for three doses plus ascorbic acid (3000 mg one dose) before angiography and 2000 mg two doses after angiography and good hydration
Number of subjects: 105

Group type: COMPARATOR
Intervention: Hydration with 0.9% saline started just before contrast media injection and continued for 12 h at a rate 1.0 mL/kg/min after angiography or 0.5 mL/kg/h in cases with overt heart failure for 12 h
Number of subjects: 105
Study: 25194928

Group type: EXPERIMENTAL
Intervention: Virtual reality training (EG)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional physiotherapy or occupational therapy (Control)
Number of subjects: 60
Study: 22245458

Group type: EXPERIMENTAL
Intervention: Tube shunt (350‐mm² Baerveldt glaucoma implant)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Trabeculectomy with mitomycin C (0.4 mg/mL for 4 minutes)
Number of subjects: 212
Study: 19584820

Group type: EXPERIMENTAL
Intervention: Glycosylated G-CSF
Number of subjects: 86

Group type: COMPARATOR
Intervention: Non-glycosylated G-CSF
Number of subjects: 86
Study: 17706004

Group type: EXPERIMENTAL
Intervention: Darifenacin (7.5 mg once daily for 2 weeks, then optional titration to 15 mg daily)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Placebo (with sham titration)
Number of subjects: 400
Study: 16080839

Group type: EXPERIMENTAL
Intervention: bisoprolol
Number of subjects: 92

Group type: COMPARATOR
Intervention: captopril
Number of subjects: 92
Study: 12034650

Group type: EXPERIMENTAL
Intervention: (192)Ir radiation
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 9929503

Group type: EXPERIMENTAL
Intervention: tizanidine HCl, 4 mg t.i.d. for seven consecutive doses
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: baclofen, 10 mg t.i.d. for seven consecutive doses
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: both regimens simultaneously for seven consecutive doses
Number of subjects: 15
Study: 8552457

Group type: EXPERIMENTAL
Intervention: Three-dimensional model of a house with raised-line drawing kit
Number of subjects: 30

Group type: COMPARATOR
Intervention: Prior information about the nature of the tangible pictures (side view, bird's-eye, top view, or 3/4 view)
Number of subjects: 30
Study: 2359305

Group type: EXPERIMENTAL
Intervention: Retrospective diary measure
Number of subjects: 156

Group type: COMPARATOR
Intervention: 28‐day Q‐F measure
Number of subjects: 156

Group type: COMPARATOR
Intervention: Standard instructions with confidentiality verification
Number of subjects: 156

Group type: COMPARATOR
Intervention: 7‐day Q‐F measure
Number of subjects: 156
Study: 11144

Group type: EXPERIMENTAL
Intervention: Cimetidine 50 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Cimetidine 100 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Cimetidine 200 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Cimetidine 400 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 29945431

Group type: COMPARATOR
Intervention: Sufentanil 0 ng/mL
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sufentanil 0.25 ng/mL
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sufentanil 0.5 ng/mL
Number of subjects: 60
Study: 28655357

Group type: EXPERIMENTAL
Intervention: Pharmacist intervention as part of a hospital ward team
Number of subjects: 212
Study: 26228205

Group type: EXPERIMENTAL
Intervention: Virtual Reality Training with Cognitive Load (VRTCL) for 4 weeks (30 min per day, five times a week)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (virtual reality treadmill training)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Virtual Reality Training with Cognitive Load (VRTCL)
Number of subjects: 22
Study: 23542157

Group type: EXPERIMENTAL
Intervention: Electroacupuncture at 2 Hz, 0.4 ms to right LI4 and LI11 for 30 min
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Electroacupuncture stimulation to bilateral patellae
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sham electroacupuncture to right LI4 and LI11 over Duoderm pads
Number of subjects: 36
Study: 21724699

Group type: EXPERIMENTAL
Intervention: UCLA SCTC GIT 2.0
Number of subjects: 115
Study: 19258524

Group type: EXPERIMENTAL
Intervention: Ibuprofen (IBU) 12.5 mg/kg and Pseudoephedrine (PSE) HCl 15 or 30 mg
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: Ibuprofen (IBU) 12.5 mg/kg
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: Pseudoephedrine (PSE) HCl 15 or 30 mg
Number of subjects: 318

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 318
Study: 16957639

Group type: EXPERIMENTAL
Intervention: RIC device (silver-coated endotracheal tube)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Control endotracheal tube
Number of subjects: 149
Study: 15316843

Group type: EXPERIMENTAL
Intervention: Temporary DDD pacing at 90 bpm
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Temporary DDD pacing at 110 bpm
Number of subjects: 6

Group type: COMPARATOR
Intervention: No pacing
Number of subjects: 6
Study: 11941377

Group type: EXPERIMENTAL
Intervention: Paracetamol 1000 mg
Number of subjects: 500

Group type: COMPARATOR
Intervention: Paracetamol 600-650 mg
Number of subjects: 500
Study: 9780137

Group type: EXPERIMENTAL
Intervention: 1.75% THC
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 3.55% THC
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 7540794

Group type: EXPERIMENTAL
Intervention: Alfuzosin (7.5 to 10 mg a day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2587847

Group type: EXPERIMENTAL
Intervention: EPA-rich omega-3 fatty acids at 3g/d
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: EPA-rich omega-3 fatty acids at 6g/d
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: EPA-rich omega-3 fatty acids at 12g/d
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 11564

Group type: EXPERIMENTAL
Intervention: H2-receptor antagonists (metiamide and cimetidine)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 31830933

Group type: EXPERIMENTAL
Intervention: New Hope
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Elders' Resilience
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: New Hope followed by Elders' Resilience
Number of subjects: 304

Group type: COMPARATOR
Intervention: Optimized Case Management
Number of subjects: 304
Study: 28134543

Group type: EXPERIMENTAL
Intervention: Evaluative statements (ES)
Number of subjects: 6492

Group type: EXPERIMENTAL
Intervention: Repeated evaluative pairings (REP)
Number of subjects: 6492

Group type: EXPERIMENTAL
Intervention: Combination of evaluative statements and repeated evaluative pairings (ES + REP)
Number of subjects: 6492

Group type: EXPERIMENTAL
Intervention: Implicit Association Test (IAT)
Number of subjects: 6492
Study: 26248813

Group type: EXPERIMENTAL
Intervention: Dronabinol (5mg daily)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 23594265

Group type: EXPERIMENTAL
Intervention: Internet-based echocardiography resource
Number of subjects: 28

Group type: COMPARATOR
Intervention: Traditional methods (non-internet group)
Number of subjects: 28
Study: 21971704

Group type: EXPERIMENTAL
Intervention: Duke Activity Status Index (DASI) questionnaire
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Duke Activity Status Index (DASI) questionnaire with age consideration
Number of subjects: 200
Study: 19522862

Group type: EXPERIMENTAL
Intervention: Male circumcision
Number of subjects: 455
Study: 16918719

Group type: EXPERIMENTAL
Intervention: Fluvoxamine (100 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Fluvoxamine (100 mg) and Erythromycin (1500 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 15546255

Group type: EXPERIMENTAL
Intervention: Combination therapy of thymalfasin (thymosin-alpha 1) and peginterferon alfa-2a
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 0
Study: 11342732

Group type: EXPERIMENTAL
Intervention: Heating and humidifying CO2
Number of subjects: 40

Group type: COMPARATOR
Intervention: Awake laparoscopy without heating and humidifying CO2
Number of subjects: 40
Study: 9791292

Group type: EXPERIMENTAL
Intervention: Interplak toothbrush
Number of subjects: 56

Group type: COMPARATOR
Intervention: Manual toothbrush
Number of subjects: 56
Study: 30274649

Group type: EXPERIMENTAL
Intervention: Transdiagnostic Sleep and Circadian Intervention for Youth (TranS‐C)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Psychoeducation (PE)
Number of subjects: 176
Study: 26940686

Group type: EXPERIMENTAL
Intervention: Capecitabine maintenance therapy
Number of subjects: 274

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 274
Study: 25391864

Group type: EXPERIMENTAL
Intervention: 80 kV, Iodixanol (320 mgI/ml), SAFIRE
Number of subjects: 135

Group type: COMPARATOR
Intervention: 80 kV, Iopamidol (370 mgI/ml), SAFIRE
Number of subjects: 135

Group type: COMPARATOR
Intervention: 100 kV, Iodixanol, FBP
Number of subjects: 135
Study: 23461283

Group type: EXPERIMENTAL
Intervention: Brimonidine
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: Acetazolamide
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: Latanoprost
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: Travoprost
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: Brinzolamide
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: Timolol
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: Bimatoprost
Number of subjects: 323

Group type: COMPARATOR
Intervention: No IOP-lowering medication
Number of subjects: 323
Study: 19362280

Group type: EXPERIMENTAL
Intervention: Single-item search task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Parallel search task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Serial search task
Number of subjects: 0
Study: 17049662

Group type: EXPERIMENTAL
Intervention: 1-year lifestyle intervention by Certified Expert Nurse (CEN)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 134
Study: 14740283

Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa
Number of subjects: 314

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 314
Study: 11484098

Group type: EXPERIMENTAL
Intervention: HEBP (200 mg per day for 2 weeks, followed by 2 g calcium lactate and 0.5 microg alphacalcidol per day for 10 weeks, repeated for 2 years)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ca. D (2 g calcium lactate and 0.5 microg alphacalcidol per day for 2 years)
Number of subjects: 40
Study: 9710840

Group type: EXPERIMENTAL
Intervention: Formula PO (palm olein 45%)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Formula HOS (high-oleic safflower oil 42%)
Number of subjects: 10
Study: 7989978

Group type: EXPERIMENTAL
Intervention: Transcatheter arterial chemoembolization therapy using iodized oil (Lipiodol) before PET study
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: FDG-PET
Number of subjects: 30
Study: 2742469

Group type: EXPERIMENTAL
Intervention: Benzocaine spray
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Air spray
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (air spray)
Number of subjects: 0
Study: 1234015

Group type: EXPERIMENTAL
Intervention: Cardiorytmin Retard (sustained-release preparation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pronestyl (conventional formulation)
Number of subjects: 0
Study: 30815685

Group type: EXPERIMENTAL
Intervention: HCMV glycoprotein B/MF59 vaccine
Number of subjects: 0
Study: 28383466

Group type: EXPERIMENTAL
Intervention: Needle decompression at the 2nd intercostal space (2MCL)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Needle decompression at the 5th intercostal space along the anterior axillary line (5AAL)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Various devices used for decompression (14G AC, 10G AC, mVN, LT)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Thoracoscopy evaluation
Number of subjects: 7
Study: 26505753

Group type: EXPERIMENTAL
Intervention: Blood- plus liver-stage drugs (chloroquine [CQ], 3 d; artemether-lumefantrine [AL], 3 d; primaquine [PQ], 20 d, 10 mg/kg total dose)
Number of subjects: 504

Group type: COMPARATOR
Intervention: Blood-stage drugs only (CQ, 3 d; AL, 3 d; placebo [PL], 20 d)
Number of subjects: 504
Study: 23102821

Group type: COMPARATOR
Intervention: Ongoing medication algorithm alone (medication only)
Number of subjects: 808

Group type: EXPERIMENTAL
Intervention: Medication plus cognitive behavioral analysis system of psychotherapy
Number of subjects: 808

Group type: EXPERIMENTAL
Intervention: Medication plus brief supportive psychotherapy
Number of subjects: 808
Study: 22108748

Group type: EXPERIMENTAL
Intervention: Norwegian version of the fecal incontinence quality-of-life scale (FIQLS)
Number of subjects: 76
Study: 18973027

Group type: EXPERIMENTAL
Intervention: Gancao Fuzi Decoction
Number of subjects: 100

Group type: COMPARATOR
Intervention: Votalin sustained released tablets
Number of subjects: 100
Study: 17384514

Group type: COMPARATOR
Intervention: Open TME
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Laparoscopic TME
Number of subjects: 74
Study: 14762035

Group type: EXPERIMENTAL
Intervention: High-dose formulation (n = 1827): 25 mg of pyridoxine, 0.4 mg of cobalamin, and 2.5 mg of folic acid
Number of subjects: 3680

Group type: COMPARATOR
Intervention: Low-dose formulation (n = 1853): 200 microg of pyridoxine, 6 microg of cobalamin, and 20 microg of folic acid
Number of subjects: 3680

Group type: EXPERIMENTAL
Intervention: High-dose formulation
Number of subjects: 3680

Group type: COMPARATOR
Intervention: Low-dose formulation
Number of subjects: 3680
Study: 12594878

Group type: EXPERIMENTAL
Intervention: Linezolid 600 mg twice daily (intravenously or orally)
Number of subjects: 0
Study: 9039837

Group type: EXPERIMENTAL
Intervention: 55 mmol/L glucose solution
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 110 mmol/L glucose solution
Number of subjects: 6

Group type: COMPARATOR
Intervention: Glucose-free solution
Number of subjects: 6
Study: 7897947

Group type: EXPERIMENTAL
Intervention: Compression of the ipsilateral common carotid artery
Number of subjects: 58
Study: 3228775

Group type: EXPERIMENTAL
Intervention: 0.5% cyclopentolate plus 0.5% tropicamide
Number of subjects: 20

Group type: COMPARATOR
Intervention: 1% cyclopentolate alone
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Combination drop
Number of subjects: 20
Study: 31095868

Group type: EXPERIMENTAL
Intervention: 1-mL syringe with 30-G needle
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 3-mL syringe with 30-G needle
Number of subjects: 20
Study: 28222701

Group type: EXPERIMENTAL
Intervention: Rocuronium (0.6 mg.kg‐1)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 15
Study: 26174323

Group type: EXPERIMENTAL
Intervention: Active Recovery (ACT)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Cold Water Immersion (CWI)
Number of subjects: 21
Study: 23638141

Group type: EXPERIMENTAL
Intervention: Titration at 0.5 μg/ml
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Titration at 0.2 μg/ml
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Titration at 0.1 μg/ml
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Induction Ce of propofol at 0.5 μg/ml
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Induction Ce of propofol at 0.2 μg/ml
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Induction Ce of propofol at 0.1 μg/ml
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Adjustment frequency at 0.1 μg/ml
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Patients requiring no further adjustment
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Patients requiring at least one adjustment
Number of subjects: 144
Study: 22046693

Group type: EXPERIMENTAL
Intervention: Endoflas
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Zinc oxide eugenol
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Metapex
Number of subjects: 45
Study: 19185677

Group type: EXPERIMENTAL
Intervention: Hormonal method
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Male condom
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Traditional method
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: No method
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Unmet need for contraception
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Low knowledge of contraceptive effectiveness
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Low self‐efficacy to negotiate condom use
Number of subjects: 192
Study: 17259914

Group type: EXPERIMENTAL
Intervention: Active stimulation group
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham stimulation group
Number of subjects: 20
Study: 14693162

Group type: EXPERIMENTAL
Intervention: rhGM‐CSF (2.8 microg/kg body weight)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 16
Study: 11194114

Group type: EXPERIMENTAL
Intervention: 70% CHO diet during high-intensity exercise trial
Number of subjects: 5

Group type: COMPARATOR
Intervention: 45% CHO diet during high-intensity exercise trial
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Both trials (70% CHO and 45% CHO)
Number of subjects: 5
Study: 9605087

Group type: EXPERIMENTAL
Intervention: Oxygenated blood cardioplegia
Number of subjects: 61

Group type: COMPARATOR
Intervention: Oxygenated crystalloid cardioplegia
Number of subjects: 61
Study: 8155440

Group type: EXPERIMENTAL
Intervention: Supinated forearm with wrist extended (group A)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Hand strapped into a fist and laid supine (group B)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Scaphoid pressure applied to all patients
Number of subjects: 40
Study: 3293726

Group type: EXPERIMENTAL
Intervention: 0.5% levobunolol hydrochloride
Number of subjects: 27

Group type: COMPARATOR
Intervention: 0.5% timolol maleate
Number of subjects: 27